All News

Top articles of the week from The American Journal of Pharmacy Benefits.

Officials with the FDA have expanded the approval of sunitinib malate (Sutent, Pfizer) for adjuvant treatment in adult patients who are at high risk of kidney cancer returning after kidney removal.

Community pharmacists are central to public health emergency planning and response efforts.

Medicare sequester cuts could restrict access to care for seniors with cancer.

Doubling Medicare sequester cuts could reduce access to lower-cost cancer treatment.

Approximately 46% of Americans have high blood pressure, according to revised guidelines.

Mid-range levels of phosphate in the blood may reduce the risk of heart attack.

Only 15% of patients with a 20% to 24% risk of breast cancer received a recommended MRI screening.

Less than half of diabetic foot ulcers heal within 1 year.

The FDA created a framework to create safe and effective regenerative medicine products.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

In this clip taken at the American Heart Association 2017 Scientific Sessions, Amar Bhakta, MD, from Rush University Medical Center, explains the crucial role that pharmacists play in the management of heart failure. Pharmacists are in a unique position to provide patient education, ensure medication adherence, and assess the patient's symptoms.

A look at last week's top stories in the world of pharmacy.

In this clip taken at the American Heart Association's 2017 Scientific Sessions, Amar Bhakta, MD, of Rush University Medical Center, discusses the results from his hospital's clinical pathway for heart failure, which includes using multidisciplinary teams to prevent and reduce hospital readmissions.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pharmacists are ranked as one of the top most-trusted professions, but what happens when they make mistakes?

With the smart tablets coming to market in 2018, it is a good time to explore how the technology behind the product works.

The holiday presents a great opportunity for pharmacists to help educate patients.

Here are ways for pharmacists to relieve foot and leg aches after a long shift.

A team of researchers have assessed supertherapeutic doses of NSAIDs, opioids, and benzodiazepines.

Sunitinib malate (Sutent) is an adjuvant therapy for adults at risk of recurrent renal cell carcinoma following nephrectomy.

Sunitinib malate (Sutent) may improve disease-free survival among patients with renal cell carcinoma.

Officials with the FDA have approved emicizumab-kxwh (Hemlibra, Genentech) as a treatment for patients with hemophilia A who have factor VIII inhibitors, according to a press release from the agency.

Officials with the FDA have approved obinutuzumab (Gazyva, Genentech) in combination with chemotherapy, followed by obinutuzumab alone, for the first-line treatment of patients with advanced follicular lymphoma, according to the company's press release.

Emicizumab-kxwh is administered as a weekly subcutaneous injection to restore clotting ability in patients with hemophilia.

Emicizumab-kxwh (Hemlibra) demonstrated the ability to reduce bleeding events that require treatment in patients with hemophilia A.

Fulvestrant (Faslodex) plus abemaciclib may improve progression-free survival among patients with advanced or metastatic breast cancer.